MMV009085

• CAT Number: I041138
• CAS Number: 298217-59-1
• Molecular Formula: C22H22N2O6
• Molecular Weight: 410.42
• Purity: ≥95%
• Synonyms: 6,13-bis(4-hydroxybutyl)-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),2,4(16),8,10-pentaene-5,7,12,14-tetrone
• InChI: InChI=1S/C22H22N2O6/c25-11-3-1-9-23-19(27)13-5-7-15-18-16(8-6-14(17(13)18)20(23)28)22(30)24(21(15)29)10-2-4-12-26/h5-8,25-26H,1-4,9-12H2
• InChIKey: XZBVMYTVRGGDKI-UHFFFAOYSA-N
• SMILES: C1=CC2=C3C(=CC=C4C3=C1C(=O)N(C4=O)CCCCO)C(=O)N(C2=O)CCCCO

MMV009085 is a potent PfHT1 (Plasmodium falciparum hexose transporter)-specific inhibitor and a potential anti-malarial agent . MMV009085 is also a human glucose transporter inhibitor, it has high potency in inhibiting both glucose uptake (IC50: 2.6 μM in glucose uptake assay) and growth of the parasites (EC50: 1.23±0.04 μM against 3D7)[1].
MMV009085 inhibits the transport activity of PfHT-1 with an IC50 of 212 ± 39 μM, the EC50 values of MMV009085 in the parasite growth inhibition assay are 1.23 ± 0.04 μM against 3D7 and 0.720 ± 0.05 μM against Dd2. MMV009085 displays significant cytotoxicity with CC50 values of 2.46 ± 0.03 μM and 1.92 ± 0.85 μM for HEK293T and HepG2 cells, respectively[1].
MMV009085 shows IC50 of 2.6 μM in  glucose uptake assay in freed parasites, MMV009085 shows an EC50 of 0.987 μM for inhibition of growth of P. falciparum strain 3D7 in in vitro growth inhibition assay, this compound acts through PfHT blockage to inhibit parasite growth ( EC50=0.795 μM).[2].

Reference

[1]. Xin Jiang, et al. Structural Basis for Blocking Sugar Uptake into the Malaria Parasite Plasmodium falciparum.Cell. 2020 Oct 1;183(1):258-268.e12.
 [Content Brief]